Safety and efficacy of quinidine sulfate in slow-channel congenital myasthenic syndrome

C. Michel Harper, Andrew G Engel

Research output: Contribution to journalArticle

8 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)203-206
Number of pages4
JournalAnnals of the New York Academy of Sciences
Volume841
DOIs
StatePublished - 1998

Fingerprint

Congenital Myasthenic Syndromes
Quinidine
Safety

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Safety and efficacy of quinidine sulfate in slow-channel congenital myasthenic syndrome. / Harper, C. Michel; Engel, Andrew G.

In: Annals of the New York Academy of Sciences, Vol. 841, 1998, p. 203-206.

Research output: Contribution to journalArticle

@article{b647e7c48f774219ae8bd0a3a23260fc,
title = "Safety and efficacy of quinidine sulfate in slow-channel congenital myasthenic syndrome",
author = "Harper, {C. Michel} and Engel, {Andrew G}",
year = "1998",
doi = "10.1111/j.1749-6632.1998.tb10929.x",
language = "English (US)",
volume = "841",
pages = "203--206",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Safety and efficacy of quinidine sulfate in slow-channel congenital myasthenic syndrome

AU - Harper, C. Michel

AU - Engel, Andrew G

PY - 1998

Y1 - 1998

UR - http://www.scopus.com/inward/record.url?scp=0031927397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031927397&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.1998.tb10929.x

DO - 10.1111/j.1749-6632.1998.tb10929.x

M3 - Article

C2 - 9668241

AN - SCOPUS:0031927397

VL - 841

SP - 203

EP - 206

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -